Response to upadacitinib monotherapy in a patient with eczematid-like pigmented purpuric dermatosis

Response to upadacitinib monotherapy in a patient with eczematid-like pigmented purpuric dermatosis

Saved in:

Bibliographic Details
Main Authors:	Aditi Chokshi, DO, Anna Agaronov, DO, Uros Rakita, MD, MSc, Penelope Hirt, MD, Francisco Kerdel, MD
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	JAAD Case Reports
Subjects:	JAK inhibitor pigmented purpuric dermatosis upadacitinib
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512624004144
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pigmented purpuric dermatoses: A review
by: Neema Shekhar, et al.
Published: (2024-01-01)

Purpuric pityriasis rosea in patients with anorexia nervosa
by: Giulia Ciccarese, et al.
Published: (2025-01-01)

Successful Achievement of Demanding Outcomes in Upadacitinib-Treated Atopic Dermatitis Patients: A Real-World, 96-Week Single-Centre Study
by: Stamatios Gregoriou, et al.
Published: (2025-01-01)

A histopathological overlap of linear IgA bullous dermatosis and vasculitis
by: Tharani Murali, MHS, et al.
Published: (2025-02-01)

Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis
by: Twan Sia, BA, et al.
Published: (2025-05-01)

Case report: Generalized granuloma annulare successfully treated with baricitinib in two cases
by: Marina Yunoki, et al.
Published: (2025-01-01)

Refractory Chronic Hand Eczema Responds to Oral Upadacitinib
by: Nada Alghamdi, et al.
Published: (2025-01-01)

Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
by: Shiyi Wang, et al.
Published: (2025-02-01)

An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
by: Hongzhen Wu, et al.
Published: (2025-01-01)

Dual immunomodulator therapy with adalimumab and upadacitinib to treat recalcitrant hidradenitis suppurativa
by: Zahidul Islam, BA, et al.
Published: (2025-02-01)

Facial Discoid Dermatosis, a Still Unknown Entity
by: Clotilde Fera, et al.
Published: (2025-01-01)

Ionized Plasma Jet Therapy in Removal of Dermatosis Papulosa Nigra
by: Ajay Dodeja, et al.
Published: (2025-01-01)

Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study
by: Filip Van den Bosch, et al.
Published: (2025-02-01)

Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system
by: Yixuan Yang, et al.
Published: (2025-01-01)

Dermatosis purpúrica pigmentada. A propósito de un caso con localización atípica
by: Daymí Martínez Rodríguez
Published: (2019-04-01)

A Case of Acquired Reactive Perforating Dermatosis with Complete Resolution of Eruptions on Upper and Lower Limbs During the Treatment of Diabetes Mellitus and Peripheral Artery Disease
by: Yoshihito Mima, et al.
Published: (2024-12-01)

A cross-sectional study to determine prevalence of neonatal dermatoses in a tertiary health care centre of Andhra Pradesh, South India
by: Deepti Vemu, et al.
Published: (2024-07-01)

Linear IgA bullous dermatosis–a fifty year experience of Warsaw Center of bullous diseases
by: Cezary Kowalewski, et al.
Published: (2025-01-01)

CANDLE syndrome – a narrative review
by: Aleksandra Snopkowska, et al.
Published: (2024-09-01)

Successful treatment of etanercept- and adalimumab-resistant pyoderma gangrenosum with spesolimab, moderate-dose corticosteroids, and minocycline
by: Hanlin Zhang, et al.
Published: (2025-12-01)

Reflectance Confocal Microscopy of Sweet Syndrome
by: Francois Skowron, et al.
Published: (2025-01-01)

Erythematous Annular and Polycyclic Lesions with Central Hyperpigmentation: A Quiz
by: Eglė Janušonytė, et al.
Published: (2025-01-01)

Complete Resolution of Hemodialysis-induced Pseudoporphyria after Renal Transplantation
by: Prodip Kumar Doley, et al.
Published: (2024-12-01)

Bullous pemphigoid treated with baricitinib as steroid-sparing therapy for a patient with uncontrolled diabetes
by: Ji Won Heo, MD, et al.
Published: (2025-03-01)

Half-filled or half-empty: Conundrum of “Hypopyon Sign” in pustular psoriasis
by: Kunal Chandwar, et al.
Published: (2022-01-01)

JAK inhibitors: a new choice for diabetes mellitus?
by: Mengjun Zhou, et al.
Published: (2025-01-01)

Baricitinib represses the myocardial fibrosis via blocking JAK/STAT and TGF-β1 pathways in vivo and in vitro
by: Renlei Feng, et al.
Published: (2025-01-01)

Diagnostic Dilemma of Leukemoid Reaction in Pediatric Pyoderma Gangrenosum
by: Snehal Umesh Chopade, et al.
Published: (2024-12-01)

Tofacitinib and budesonide treatment affect stemness and chemokine release in IBD patient-derived colonoids
by: Arun Sridhar, et al.
Published: (2025-01-01)

Nootkatone Derivative Nootkatone-(E)-2-iodobenzoyl hydrazone Promotes Megakaryocytic Differentiation in Erythroleukemia by Targeting JAK2 and Enhancing JAK2/STAT3 and PKCδ/MAPK Crosstalk
by: Yang Pan, et al.
Published: (2024-12-01)

Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors
by: Elisabet Castañeda-Estévez, et al.
Published: (2024-12-01)

Dermatosis en pacientes geriátricos
by: Dagmaris Albear de la Torre, et al.
Published: (2021-04-01)

ON THE PROBLEM OF THE TREATMENT OF GENITAL LICHEN PLANUS
by: Yu. A. Molochkova
Published: (2016-06-01)

Biomimetic polydopamine loaded with janus kinase inhibitor for synergistic vitiligo therapy via hydrogel microneedles
by: Chunying Li, et al.
Published: (2025-01-01)

JAK2, STAT3 Gene Polymorphisms in Turkish Patients with Behçet’s Disease
by: Darya Farhoomand Aksoy, et al.
Published: (2024-01-01)

Monocyte STAT1 phosphorylation and treatment response of JAK inhibitors in chronic nonbacterial osteomyelitis
by: Motoshi Sonoda, et al.
Published: (2025-01-01)

Refractory pityriasis rubra pilaris treated with abrocitinib
by: Filip Rob
Published: (2025-01-01)

Relation of JAK2 V617F allele burden and coronary calcium score in patients with essential thrombocythemia
by: Drofenik Ajda, et al.
Published: (2024-10-01)

A Threefold Association Between Vitiligo and Alopecia Areata: Results from a Nationwide Case-control Observational Study
by: Yonit Wohl, et al.
Published: (2025-02-01)

Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway
by: Wang Guanglian, et al.
Published: (2025-01-01)